Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 May;78(5):163-168.

Staphylococcus aureus Antibiotic Susceptibilities in Infections in an Outpatient Dermatology Office on O'ahu

Affiliations
Observational Study

Staphylococcus aureus Antibiotic Susceptibilities in Infections in an Outpatient Dermatology Office on O'ahu

Kimberly R Theos et al. Hawaii J Med Public Health. 2019 May.

Abstract

Staphylococcus aureus is a pathogen that causes skin and soft tissue infections (SSTIs) in dermatology patients. There is an increasing rate of methicillin-resistant S aureus (MRSA) reported in the dermatology literature since 1987. This report profiles the antibiotic susceptibilities of methicillin-sensitive S aureus (MSSA) and MRSA in an outpatient office in Hawai'i. This is a retrospective study done by chart review from 2012 to 2014. Demographics, anatomical site of infection, clinical diagnoses and antimicrobial susceptibility patterns were analyzed and compared. Of the 66 samples, 57% were males and 43% were females. S aureus was more commonly found in impetigo, folliculitis, furuncles and secondarily infected psoriasis and more commonly located on the extremities. MSSA accounted for 73% (48) of the cases and MRSA accounted for 27% (18) of the cases. The antibiotics most effective against all S aureus cultures for outpatients were linezolid (100%), trimethoprim sulfamethoxazole (95%) and tetracyclines (94%). Linezolid (100%), trimethoprim sulfamethoxazole (100%) were most effective against MRSA isolates. Our S aureus and MRSA antimicrobial susceptibility results are similar to the local Hawai'i outpatient antibiogram collected from a large private laboratory in Hawai'i in 2014 and the current Infectious Disease Society of America guidelines. This study may be helpful in guiding empiric treatment of SSTIs suspected to be caused by S aureus.

Keywords: Hawai‘i; Staphylococcus aureus; antimicrobial susceptibility; dermatology; methicillin-resistant S aureus; methicillin-sensitive S aureus; outpatient.

PubMed Disclaimer

Conflict of interest statement

None of the authors identify any conflicts of interest.

Figures

Figure 1
Figure 1
S aureus Cultures by Patient Sex.
Figure 2
Figure 2
S aureus Cultures by Patient Age Groups.

Similar articles

Cited by

References

    1. Centers for Disease Control and Prevention Community associated MRSA and Health Care associated MRSA information for clinicians, author. [10 March 2018]. Available at http://www.cdc.gov/mrsa.
    1. Tong SY, David JS, Eichenberger E, Holland TL, Fowler VG., Jr. Staphylococcus aureus infections: epidemiology, pathphysiology, clinical manifestations, and management. Clin Microbial Rev. 2015;28(3):603–661. - PMC - PubMed
    1. Loewen K, Schreiber Y, Kirlew M, Bocking N, Kelly L. Community-associated methicillin-resistant Staphylococcus aureus infections: Literature review and clinical update. Can Fam Physician. 2017;63(7):512–520. - PMC - PubMed
    1. McBride ME, Schaefer D, Rudolph AH, Aldama S, Wolf JE., Jr. Evaluation of antibacterial sensitivity testing methods for methicillin-resistant Staphylococcus aureus in a dermatology outpatient population. South Med J. 1989;82(2):165–168. - PubMed
    1. Price MF, McBride ME, Wolf JE., Jr. Prevalence of methicillin-resistant Staphylococcus aureus in a dermatology outpatient population. South Med J. 1998 Apr;91(4):369–371. - PubMed

Publication types

Substances